Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02979626 · ClinicalTrials.gov registry record
Evaluation of Moderate to Severe Influenza Outcomes in Children
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 1,478
- Enrollment target
NCT02979626 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 1,478 participants.
The verdict
NCT02979626 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 1,478 participants
- Enrollment target
Study Summary
The purpose of this study was to determine whether moderate-severe endpoints (including high fever, lower respiratory tract disease, acute otitis media, or serious extra-pulmonary complications) were predictive of hospitalization, intensive care admission, antibiotic use and other complications in children under 8 years of age.
Interventions
- PROCEDURE Respiratory nasal swab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,478 participants |
| Start Date | 2017-01-30 |
| Est. Completion | 2018-05-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02979626
The ClinicalTrials.gov registry entry for NCT02979626 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,478 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Respiratory nasal swab is the first listed.
NCT02979626 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02979626 about?
NCT02979626 is a clinical study titled "Evaluation of Moderate to Severe Influenza Outcomes in Children". The purpose of this study was to determine whether moderate-severe endpoints (including high fever, lower respiratory tract disease, acute otitis media, or serious extra-pulmonary complications) were predictive of hospitalization, intensive care admission, antibiotic use and other complications in c...
What is the current status of trial NCT02979626?
This trial is currently completed. The enrollment target is 1,478 participants. The study started on 2017-01-30. Estimated completion is 2018-05-05.
What interventions are being tested in trial NCT02979626?
The interventions under investigation include: Respiratory nasal swab (PROCEDURE).
Who is sponsoring clinical trial NCT02979626?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.